Document is current
Any future updates will be listed below
-
Authors
Bejaoui, Yosra
Srour, Luma
Qannan, Abeer
Oshima, Junko
Saad, Chadi
Horvath, Steve
Mbarek, Hamdi
El Hajj, Nady https://orcid.org/0000-0003-3420-8531
-
Funding
Funding for this research was provided by:
Qatar Foundation
Qatar Foundation
- License Information
-
More Information
Article History
Received: 26 December 2024
Accepted: 24 January 2025
First Online: 10 February 2025
Declarations
:
: The Institutional Review Board at Qatar BioBank approved the study with record numbers E- 2022-QF- QBB-RES-ACC-00100–0203. All research was performed according to the ethical principles of the Declaration of Helsinki.
: Not applicable.
: SH and his team developed the first epigenetic clocks for human saliva, for all tissues (pan-tissue clock), for human mortality risk prediction (PhenoAge, GrimAge), and pan-mammalian clocks. The Regents of the University of California are the sole owner of patents and patent applications directed at epigenetic biomarkers for which SH is a named inventor; SH is a founder and paid consultant of the non-profit Epigenetic Clock Development Foundation that licenses these patents. SH is a principal Investigator at the Altos Labs, Cambridge Institute of Science. The other authors declare no conflict of interests.
